New schizophrenia shot tested against standard treatment
NCT ID NCT07268430
First seen Dec 16, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study tested whether a new version of a long-acting schizophrenia injection works the same as the current standard. 256 Chinese adults with stable schizophrenia received multiple doses of either the test or reference injection. The goal was to confirm the two medications reach similar levels in the body, not to cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Anding Hospital Capital Medical University
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.